Sg3 Management, LLC Profound Medical Corp. Call Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$13.6 - $17.88 $680,000 - $894,000	-50,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.0 - $20.59 $134,400 - $172,956	-8,400 Reduced 14.38%	50,000 $818,000
Q4 2020 Feb 16, 2021	BUY	$16.4 - $22.9 $275,520 - $384,720	16,800 Added 40.38%	58,400 $1.2 Million
Q3 2020 Nov 13, 2020	BUY	$14.05 - $18.13 $584,480 - $754,208	41,600 New	41,600 $734,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.